Health Care

    CKD BiO

    CKD BiO is expanding its presence to the world market by utilizing its competitive edge in the bio APIs business line.

    CKD BiO was split from Chong Kun Dang in November of 2011. CKD BiO plans to expand its growth as a leading global company by high quality medicine supplies and probiotics production, continuous exports, and focused efforts on micro-biome R&D (Research & Development) based on its leading fermentation technology.

    Link to CKD BiO
    CKD BiO
    CEO

    Wan-Kap, Park
    Foundation

    November 12, 2001
    Business Line

    Manufacturing/Sales of Medicine Supplies
    Paid in Capital

    13,715 (million won)
    Address

    8, Chungjeong-ro, Seodaemun-gu, Seoul, Korea (5th Floor, CKD Building)
    TEL / FAX

    82-2-2194-0555 / 82-2-2194-0556